 veins, including the GSV and SSV, perforating veins, and venous
malformations.301-311

JOURNAL OF VASCULAR SURGERY
May Supplement 2011

32S Gloviczki et al

Table VII. Sclerosing agent comparison
Agent

Manufacturer

Category

FDA approval

Strength

Advantages

Disadvantages
Off label; painful to
inject;
hyperpigmentation;
n